CervoMed Inc. is seeking market approval for a DLB treatment, with the USPTO granting allowance for a new patent.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CervoMed Inc. is seeking market approval for a DLB treatment, with the USPTO granting allowance for a new patent.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
United States Patent and Trademark Office
agency in the United States Department of Commerce
- The administration barred several media outlets from White House grounds while a private company filed a trademark application with the USPTO.
- The United States Patent and Trademark Office is addressing the establishment of professional conduct standards regarding the use of artificial intelligence in its processes.
- FDA